| comparison of the abbott realtime ct new formulation assay with two other commercial assays for detection of wild-type and new variant strains of chlamydia trachomatis. | in an analytical-method comparison study of clinical samples, the abbott realtime ct new formulation assay (m2000 real-time pcr), consisting of a duplex pcr targeting different parts of the cryptic plasmid in chlamydia trachomatis, was compared both with version 2 of the roche cobas taqman ct assay, comprising a duplex pcr for a target in the cryptic plasmid and the omp1 gene, and with the gen-probe aptima combo 2 assay (ac2) targeting the c. trachomatis 23s rrna molecule. first-catch urine samp ... | 2010 | 20007394 |
| comparison of gen-probe transcription-mediated amplification, abbott pcr, and roche pcr assays for detection of wild-type and mutant plasmid strains of chlamydia trachomatis in sweden. | the clinical performance of two nucleic acid amplification assays targeting the cryptic plasmid and two assays targeting rrna molecules in chlamydia trachomatis was examined. first-catch urine samples from malmoe, sweden, were tested for c. trachomatis with the abbott real-time pcr assay m2000 and an in-house pcr for the new variant strain of c. trachomatis with a deletion in the cryptic plasmid. aliquots of the urine samples were sent to aarhus, denmark, and further examined with the roche coba ... | 2008 | 18842934 |
| clinical manifestations and epidemiology of the new genetic variant of chlamydia trachomatis. | in 2006, a new genetic variant of chlamydia trachomatis (nvct) was discovered in sweden. clinical manifestations of this infection were studied in a high-risk population. | 2009 | 19617866 |